Reimagine Vitiligo Treatment with Lumirix®
Lumirix® is the first topical treatment approved for vitiligo.
Learn more
Why Choose Lumirix® for Your Vitiligo Treatment?
1.
Clinically Proven Results
Lumirix® is supported by clinical studies that show significant improvements in skin repigmentation.²
2.
Easy-to-Use
Designed for daily use, Lumirix® cream integrates easily into your patient's routine with a convenient twice-daily application.³
3.
Good Safety Profile
Lumirix® has a good safety and tolerability profile, making it a trusted choice for both patients and healthcare providers.²
4.
Patient Support
Find out more about the useful programs run by Vitiligo Support Group, a non-profit patient support group.
References:
- Grossmann MC, Haidari W, Feldman SR. A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo. Journal of drugs in dermatology: JDD. 2023;22
- Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D. Two phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo. New England Journal of Medicine. 2022 Oct 20;387(16):1445-55.
- Lumirix Prescribing information for Hong Kong.